Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers
Accurate staging of prostate cancer (PCa) at initial diagnosis and at biochemical recurrence is important to determine prognosis and the optimal treatment strategy. To date, treatment of metastatic PCa has mostly been based on the results of conventional imaging with abdominopelvic computed tomograp...
Main Authors: | Wietske I. Luining, Dennie Meijer, Max R. Dahele, André N. Vis, Daniela E. Oprea-Lager |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/1/117 |
Similar Items
-
Assessment of Bone Metastases in Patients with Prostate Cancer—A Comparison between 99mTc-Bone-Scintigraphy and [68Ga]Ga-PSMA PET/CT
by: Lena Thomas, et al.
Published: (2017-07-01) -
Diagnostic Accuracy of PET with Different Radiotracers versus Bone Scintigraphy for Detecting Bone Metastases of Breast Cancer: A Systematic Review and a Meta-Analysis
by: Maryam Zamanian, et al.
Published: (2023-12-01) -
Disseminated Carcinomatosis of the Bone Marrow from Castration-Resistant Prostate Cancer Revealed by Choline Positron Emission Tomography-Computed Tomography
by: Kazuhiro Kitajima, et al.
Published: (2024-06-01) -
RADIONUCLIDE DIAGNOSTICS OF BONE METASTASES IN PATIENTS WITH PROSTATE CANCER
by: E. Portnyaga, et al.
Published: (2016-09-01) -
A population-based study of the clinical utility of 18F–choline PET/CT for primary metastasis staging of high-risk prostate cancer
by: Henrik Kjölhede, et al.
Published: (2017-11-01)